Breaking News

A Supreme Court assault on public health?; Do we really need a "healthy" label on food packaging?; and more 

    

 

First Opinion

This week's smorgasbord of thoughtful and sometimes passionate First Opinion essays ranged from a concern that the U.S. Supreme Court is waging an assault on public health to a look at the Food and Drug Administration's plans for letting food companies use a "healthy" label on packaging and much, much more. Podcast fans: please check out the latest episode of the First Opinion Podcast.

Will there be a Supreme assault on public health?

By Michelle A. Williams and Lawrence O. Gostin

Drew Angerer/Getty Images

In just seven days last June, the U.S. Supreme Court set back public health by 50 years. It could do the same, or worse, this term.

Read More

FDA's plan to define 'healthy' for food packaging: Better than the existing labeling anarchy, but do we really need it?

By Marion Nestle

Adobe

The FDA has proposed rules for letting manufacturers claim that a food product is "healthy." It's a good step, but do we need such a label?

Read More

Messaging — the unrecognized coefficient in pandemic control — matters

By Jim Downs and Eleanor J. Murray

Federal Art Project/Library of Congress

Public health messaging helped stop the 1920s diphtheria epidemic in New York. It can do the same for the Covid-19 pandemic today.

Read More

Listen: Wheelchair users and Medicare disagree on what's 'primarily medical in nature'

By Patrick Skerrett

Medicare's opinion that the benefits of advanced wheelchairs aren't "primarily medical in nature" is just plain wrong, say two advocates.

Read More

Certified nursing assistants do important work. They deserve to be paid a living wage for it

By Toni Gingerelli

Adobe

Nursing homes and home-bound individuals depend on care provided by certified nursing assistants. Their work needs to be valued.

Read More

STAT+: The new law that could stealthily transform biomedical innovation

By M. Gregg Bloche and Neel U. Sukhatme and John L. Marshall

Adobe

The Inflation Reduction Act ties Medicare's payment for treatments to how well they work. That could catalyze biomedical breakthroughs.

Read More

STAT+: Interoperability can't wait: Don't delay information blocking rules

By Steven Lane

Bebeto Matthews/AP

Rules to foster interoperability and prevent information blocking have been delayed long enough. It's time they were put into action.

Read More

STAT+: How can the latest Alzheimer's therapy reach patients? Follow this trustworthy process

By Jason Karlawish

Adobe

Top-line results for treating Alzheimer's with lecanemab look promising, but there are lessons to be learned from the failure of Aduhelm.

Read More

STAT+: Needed: stricter screening of gene synthesis orders, customers

By Gigi Kwik Gronvall

Adobe

To prevent synthetic bioweapons, companies that sell raw materials for gene synthesis must be required to better screen orders and customers.

Read More

Better use of health savings accounts: lessons from Singapore

By Elise Amez-Droz and Phillip Phan

Adobe

In Singapore, much of health care is financed by mandatory individual health savings accounts. It works, at a fraction of the U.S. cost.

Read More

Sunday, October 9, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments